Tonka
Well-known member
http://www.urgente24.com/noticias/val/955/ax-1-analisis-de-sangre-en-15.html
Spanish to English translation
AX-1: Analysis of blood in 15 minutes
A new system allows blood tests in a quarter of an hour. General practitioners may use from 2013.05/12/2010 | 22:49
The results of blood tests will be in 15 minutes.
Avacta British company has launched a newly developed blood test that gives results in just 15 '. The system, called the AX-1, is a mobile laboratory for immunoassay, with which you can perform a wide range of blood tests for biomarkers linked to disease.
The first step for implementation in the market will in early 2011, when the AX-1 will go on sale to veterinarians in the UK and Europe. General practitioners may use this system from 2013. For Yaiza Mart?nez.
Avacta British company specializing in technologies and services for the pharmaceutical and diagnostics, has launched a revolutionary product: a portable diagnostic instrument that gives the results of blood tests in just fifteen minutes.
As reported in The Engineer magazine, Alastair Smith, chief executive of the company, says that this instrument, named AX-1, is already sold to veterinarians in the UK and Europe, through the division of Avacta "Animal Avacta Health.
Also, the company itself has announced in a statement that the instrument is also true for human diagnostics, and to be sold for use by GPs within three years from 2013.
What it is-
The AX-1 is a mobile laboratory for immunoassay which can perform a wide range of blood tests for biomarkers linked to disease.
The instrument has disposable tubes for blood samples. These tubes are loaded with reagents specific for each particular test.
Once the blood sample is introduced into them, the reagents react with any viruses present in the sample. The rest of the analysis is performed by the fully automatic system.
For this, the AX-1 features a standard technique known as ELISA immunoassay, the acronym for enzyme-linked immunosorbent adsorption. ELISA is a commonly used laboratory test to detect antibodies in the blood.
The AX-1 also combines measurements of chemiluminescence (the emission of light to chemical reactions) at low temperature and photomultiplier detection.
The creators of the AX-1 argue that this system will displace the blood diagnostic systems on the market.
Currently, in many cases, blood samples are taken for analysis patients should be sent to a lab for results. This process usually takes several days, a delay that could end with the AX-1.
On the other hand, according to Alastair Smith, systems of rapid blood test, could play an important role in halting the spread of hospital infections or highly infectious viruses such as Severe Acute Respiratory Syndrome (SARS) (which is a type pneumonia) or H1N1 (influenza virus).
Marketing
The first AX-1 sold by Avacta specializes in the detection of allergies in dogs. The company anticipates that, in early 2011, sold the first units of this test.
From this first step, Avacta managers expect the AX-1 becomes a key growth market of diagnostics by blood tests with mobile systems.
In the immediate future, the developers of the AX-1 hope to increase the quantity and variety of tests available to veterinarians, for the detection of various diseases or disorders of the animals.
Subsequently, Avacta aims to commercialize the system in the human diagnostics market. This market will take longer than the animal diagnosis because it has many more regulatory hurdles.
Right now, Avacta is in the process of identifying partners for this purpose. The approximate price of AX-1 is currently ? 3,500
Spanish to English translation
AX-1: Analysis of blood in 15 minutes
A new system allows blood tests in a quarter of an hour. General practitioners may use from 2013.05/12/2010 | 22:49
The results of blood tests will be in 15 minutes.
Avacta British company has launched a newly developed blood test that gives results in just 15 '. The system, called the AX-1, is a mobile laboratory for immunoassay, with which you can perform a wide range of blood tests for biomarkers linked to disease.
The first step for implementation in the market will in early 2011, when the AX-1 will go on sale to veterinarians in the UK and Europe. General practitioners may use this system from 2013. For Yaiza Mart?nez.
Avacta British company specializing in technologies and services for the pharmaceutical and diagnostics, has launched a revolutionary product: a portable diagnostic instrument that gives the results of blood tests in just fifteen minutes.
As reported in The Engineer magazine, Alastair Smith, chief executive of the company, says that this instrument, named AX-1, is already sold to veterinarians in the UK and Europe, through the division of Avacta "Animal Avacta Health.
Also, the company itself has announced in a statement that the instrument is also true for human diagnostics, and to be sold for use by GPs within three years from 2013.
What it is-
The AX-1 is a mobile laboratory for immunoassay which can perform a wide range of blood tests for biomarkers linked to disease.
The instrument has disposable tubes for blood samples. These tubes are loaded with reagents specific for each particular test.
Once the blood sample is introduced into them, the reagents react with any viruses present in the sample. The rest of the analysis is performed by the fully automatic system.
For this, the AX-1 features a standard technique known as ELISA immunoassay, the acronym for enzyme-linked immunosorbent adsorption. ELISA is a commonly used laboratory test to detect antibodies in the blood.
The AX-1 also combines measurements of chemiluminescence (the emission of light to chemical reactions) at low temperature and photomultiplier detection.
The creators of the AX-1 argue that this system will displace the blood diagnostic systems on the market.
Currently, in many cases, blood samples are taken for analysis patients should be sent to a lab for results. This process usually takes several days, a delay that could end with the AX-1.
On the other hand, according to Alastair Smith, systems of rapid blood test, could play an important role in halting the spread of hospital infections or highly infectious viruses such as Severe Acute Respiratory Syndrome (SARS) (which is a type pneumonia) or H1N1 (influenza virus).
Marketing
The first AX-1 sold by Avacta specializes in the detection of allergies in dogs. The company anticipates that, in early 2011, sold the first units of this test.
From this first step, Avacta managers expect the AX-1 becomes a key growth market of diagnostics by blood tests with mobile systems.
In the immediate future, the developers of the AX-1 hope to increase the quantity and variety of tests available to veterinarians, for the detection of various diseases or disorders of the animals.
Subsequently, Avacta aims to commercialize the system in the human diagnostics market. This market will take longer than the animal diagnosis because it has many more regulatory hurdles.
Right now, Avacta is in the process of identifying partners for this purpose. The approximate price of AX-1 is currently ? 3,500